{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:28:40Z","timestamp":1787023720207,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Uskudar University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Patient global (PtGA) and physician global (PhGA) assessments are key components of disease evaluation in axial spondyloarthritis (axSpA). Although commonly used in composite indices, these measures are often interpreted as interchangeable indicators of disease activity. It remains unclear whether PtGA and PhGA reflect overlapping or distinct clinical domains.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In this cross-sectional study, 155 patients fulfilling the modified New York criteria, with ASAS classification criteria additionally recorded, were included. All patients had radiographic and MRI-confirmed sacroiliitis. Patient-reported outcomes included PtGA (0\u201310 VAS)\n ,<\/jats:bold>\n fatigue (0\u2013100), and Beck Depression Inventory (BDI). PhGA (0\u201310 VAS) was assessed independently by the evaluating physician. Laboratory parameters included erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Spinal mobility was evaluated using the modified Schober test, tragus-to-wall distance, and chest expansion. Associations were examined using Spearman correlation and multivariate linear regression analyses including demographic variables.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n PtGA showed strong correlations with depressive symptoms (\n \u03c1<\/jats:italic>\n \u2009=\u20090.61,\n p<\/jats:italic>\n \u2009<\u20090.001) and fatigue (\n \u03c1<\/jats:italic>\n \u2009=\u20090.53,\n p<\/jats:italic>\n \u2009<\u20090.001), while correlations with inflammatory markers were weak. In multivariate analyses, BDI (\n \u03b2<\/jats:italic>\n \u2009=\u20090.087,\n p<\/jats:italic>\n \u2009<\u20090.001), fatigue (\n \u03b2<\/jats:italic>\n \u2009=\u20090.015,\n p<\/jats:italic>\n \u2009=\u20090.002), ESR (\n \u03b2<\/jats:italic>\n \u2009=\u20090.040,\n p<\/jats:italic>\n \u2009=\u20090.001), disease duration (\n \u03b2<\/jats:italic>\n \u2009=\u2009\u2009\u2212\u20090.068,\n p<\/jats:italic>\n \u2009=\u20090.036), and tragus-to-wall distance (\n \u03b2<\/jats:italic>\n \u2009=\u20090.069,\n p<\/jats:italic>\n \u2009=\u20090.040) remained independently associated with PtGA (adjusted\n R<\/jats:italic>\n 2<\/jats:sup>\n \u2009=\u20090.402), whereas spinal mobility measures were not significant. In contrast, PhGA was independently associated with modified Schober (\n \u03b2<\/jats:italic>\n \u2009=\u2009\u2009\u2212\u20090.200,\n p<\/jats:italic>\n \u2009=\u20090.031), tragus-to-wall distance (\n \u03b2<\/jats:italic>\n \u2009=\u20090.061,\n p<\/jats:italic>\n \u2009=\u20090.043), ESR (\n \u03b2<\/jats:italic>\n \u2009=\u20090.031,\n p<\/jats:italic>\n \u2009=\u20090.004), and BDI (\n \u03b2<\/jats:italic>\n \u2009=\u20090.075,\n p<\/jats:italic>\n \u2009<\u20090.001) (adjusted\n R<\/jats:italic>\n 2<\/jats:sup>\n \u2009=\u20090.434). CRP and demographic variables were not significant predictors of either global assessment.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Patient and physician global assessments capture distinct clinical domains in axSpA. PtGA is predominantly influenced by psychological burden and fatigue, whereas PhGA is more strongly associated with structural impairment and inflammatory burden. These findings highlight the multidimensional nature of disease perception and support domain-targeted clinical evaluation.<\/jats:p>\n \n \n \n \n \n \n Key Points<\/jats:bold>\n \u2022\n Patient and physician global assessments in axial spondyloarthritis reflect partially overlapping but distinct clinical domains.<\/jats:italic>\n \u2022\n Patient global assessment is primarily driven by depressive symptoms and fatigue rather than objective inflammatory or structural parameters.<\/jats:italic>\n \u2022\n Physician global assessment is independently associated with spinal mobility impairment and inflammatory burden.<\/jats:italic>\n \u2022\n Interpreting PG\u2013MD differences as domain-specific weighting rather than discordance may improve multidimensional disease assessment.<\/jats:italic>\n <\/jats:td>\n <\/jats:tr>\n <\/jats:tbody>\n <\/jats:table>\n <\/jats:table-wrap>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s10067-026-08254-0","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:47:50Z","timestamp":1782344870000},"page":"4929-4935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient and physician global assessments capture distinct clinical domains in axial spondyloarthritis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-5912","authenticated-orcid":false,"given":"Duygu","family":"Kurtulus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekrem","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"1","key":"8254_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2022","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landew\u00e9 RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, G\u00e9her P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, L\u00f3pez-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Comp\u00e1n V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D (2022) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8254_CR2","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, G\u00e9her P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Comp\u00e0n V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770","journal-title":"Ann Rheum Dis"},{"key":"8254_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/acr.24266","volume":"72","author":"A Ogdie","year":"2020","unstructured":"Ogdie A, Duarte-Garc\u00eda A, Hwang M, Navarro-Comp\u00e1n V, van der Heijde D, Mease P (2020) Measuring outcomes in axial spondyloarthritis. Arthritis Care Res (Hoboken) 72:47\u201371. https:\/\/doi.org\/10.1002\/acr.24266","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"8254_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/acr.24465","volume":"74","author":"F Hirano","year":"2022","unstructured":"Hirano F, Landew\u00e9 RBM, van Gaalen FA, van der Heijde D, Gaujoux-Viala C, Ramiro S (2022) Determinants of the physician global assessment of disease activity and influence of contextual factors in early axial spondyloarthritis. Arthritis Care Res (Hoboken) 74(2):268\u2013273. https:\/\/doi.org\/10.1002\/acr.24465","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"8254_CR5","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3899\/jrheum.150007","volume":"42","author":"C Lindstr\u00f6m Egholm","year":"2015","unstructured":"Lindstr\u00f6m Egholm C, Krogh NS, Pincus T, Dreyer L, Ellingsen T, Glintborg B, Kowalski MR, Lorenzen T, Madsen OR, Nordin H, Rasmussen C, Hetland ML (2015) Discordance of global assessments by patient and physician is higher in female than in male patients regardless of the physician\u2019s sex: data on patients with rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis from the DANBIO registry. J Rheumatol 42(10):1781\u20135. https:\/\/doi.org\/10.3899\/jrheum.150007","journal-title":"J Rheumatol"},{"issue":"9","key":"8254_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/annrheumdis-2022-222436","volume":"81","author":"S Bugatti","year":"2022","unstructured":"Bugatti S, De Stefano L, D\u2019Onofrio B, Nicrosini A, Mauric E, di Lernia M, Sakellariou G, Favalli EG, Manzo A, Caporali R, Montecucco C (2022) Inflammatory correlates of the patient global assessment of disease activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis. Ann Rheum Dis 81(9):1206\u20131213. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222436","journal-title":"Ann Rheum Dis"},{"key":"8254_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez656","author":"B Michelsen","year":"2020","unstructured":"Michelsen B, \u00d8rnbjerg L, Kvien T, Pavelka K, Nissen M, Nordstr\u00f6m D, Santos M, Koca S, Askling J, Rotar Z, Gu\u00f0bj\u00f6rnsson B, Codreanu C, Loft AG, Kristianslund E, Mann H, Ciurea A, Eklund K, Sousa E, Yazici A, \u00d8stergaard M (2020) Impact of discordance between patient\u2019s and evaluator\u2019s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis. Rheumatology (Oxford, England). https:\/\/doi.org\/10.1093\/rheumatology\/kez656","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"8254_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1644-6","volume":"20","author":"S Zhao","year":"2018","unstructured":"Zhao S, Thong D, Miller N, Duffield SJ, Hughes DM, Chadwick L, Goodson NJ (2018) The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis. Arthritis Res Ther 20(1):140. https:\/\/doi.org\/10.1186\/s13075-018-1644-6","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"8254_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/acr.24025","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L (2019) 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken) 71(10):1285\u20131299. https:\/\/doi.org\/10.1002\/acr.24025","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"8254_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 27(4):361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8254_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rky017","volume":"2","author":"NA Pearson","year":"2018","unstructured":"Pearson NA, Packham JC, Tutton E, Parsons H, Haywood KL (2018) Assessing fatigue in adults with axial spondyloarthritis: a systematic review of the quality and acceptability of patient-reported outcome measures. Rheumatol Adv Pract 2(2):rky017. https:\/\/doi.org\/10.1093\/rap\/rky017","journal-title":"Rheumatol Adv Pract"},{"issue":"11","key":"8254_CR12","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/key206.PMID:30053166;PMCID:PMC6199528","volume":"57","author":"GJ Macfarlane","year":"2018","unstructured":"Macfarlane GJ, MacDonald RIR, Pathan E, Siebert S, Gaffney K, Choy E, Packham J, Martin KR, Haywood K, Sengupta R, Atzeni F, Jones GT (2018Nov 1) Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register. Rheumatology (Oxford) 57(11):1982\u20131990. https:\/\/doi.org\/10.1093\/rheumatology\/key206.PMID:30053166;PMCID:PMC6199528","journal-title":"Rheumatology (Oxford)"},{"key":"8254_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20934277","volume":"12","author":"M Lorenzin","year":"2020","unstructured":"Lorenzin M, Ometto F, Ortolan A, Felicetti M, Favero M, Doria A, Ramonda R (2020) An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision. Ther Adv Musculoskelet Dis 12:1759720X20934277. https:\/\/doi.org\/10.1177\/1759720X20934277","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"8254_CR14","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/annrheumdis-2015-208251","volume":"75","author":"C Desthieux","year":"2016","unstructured":"Desthieux C, Dougados M, van der Heijde D, Molto A (2016) Patient\u2013physician discordance in global assessment in early spondyloarthritis and its evolution over time. Ann Rheum Dis 75(9):1661\u20131666. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208251","journal-title":"Ann Rheum Dis"},{"key":"8254_CR15","doi-asserted-by":"publisher","unstructured":"Regierer AC, Karberg K, von der Decken CB, Lembke S, Veltri C, Englbrecht M, Callhoff J, Kleinert S (2025) Discordance between patient and physician reported global disease activity in PsA is associated with mental health-a cross-sectional analysis. Rheumatol Int 45(8):181. https:\/\/doi.org\/10.1007\/s00296-025-05933-0","DOI":"10.1007\/s00296-025-05933-0"},{"issue":"6","key":"8254_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234705","volume":"15","author":"JA Sacrist\u00e1n","year":"2020","unstructured":"Sacrist\u00e1n JA, Dilla T, Diaz-Cerezo S, Gab\u00e1s-Rivera C (2020) Patient\u2013physician discrepancy in the assessment of disease activity in immune-mediated inflammatory diseases: a qualitative systematic review. PLoS ONE 15(6):e0234705. https:\/\/doi.org\/10.1371\/journal.pone.0234705","journal-title":"PLoS ONE"},{"key":"8254_CR17","unstructured":"Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21(9):1694\u20138"},{"issue":"1","key":"8254_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47\u201353. https:\/\/doi.org\/10.1136\/ard.2010.138594","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8254_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5114\/reum\/185429","volume":"62","author":"K Wi\u0105k-Walerowicz","year":"2024","unstructured":"Wi\u0105k-Walerowicz K, Wielosz E (2024) Comparison of ankylosing spondylitis disease activity score and Bath ankylosing spondylitis disease activity index tools in assessment of axial spondyloarthritis activity. Reumatologia 62(1):64\u201369. https:\/\/doi.org\/10.5114\/reum\/185429","journal-title":"Reumatologia"},{"issue":"4","key":"8254_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/ar2794","volume":"11","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde D, Salonen D, Weissman BN, Landew\u00e9 R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R (2009) Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 11(4):R127. https:\/\/doi.org\/10.1186\/ar2794","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"8254_CR21","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/1756-185X.13299","volume":"21","author":"CTM Wang","year":"2018","unstructured":"Wang CTM, Fong W, Kwan YH, Phang JK, Lui NL, Leung YY, Thumboo J, Cheung PP (2018) A cross-sectional study on factors associated with patient-physician discordance in global assessment of patients with axial spondyloarthritis: an Asian perspective. Int J Rheum Dis 21(7):1436\u20131442. https:\/\/doi.org\/10.1111\/1756-185X.13299","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"8254_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/art.21337","volume":"53","author":"WP Maksymowych","year":"2005","unstructured":"Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Krishnananthan R, Stone M, Conner-Spady B, Palsat J, Lambert RG (2005) Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis Rheum 53(4):502\u20139. https:\/\/doi.org\/10.1002\/art.21337","journal-title":"Arthritis Rheum"},{"issue":"10","key":"8254_CR23","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1002\/art.27571","volume":"62","author":"U Weber","year":"2010","unstructured":"Weber U, Lambert RG, \u00d8stergaard M, Hodler J, Pedersen SJ, Maksymowych WP (2010) The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum 62(10):3048\u201358. https:\/\/doi.org\/10.1002\/art.27571","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08254-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08254-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08254-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:16:33Z","timestamp":1787022993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08254-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8254"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08254-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the University of Health Sciences, \u00dcmraniye Training and Research Hospital (protocol code: B.10.1.TKH.4.34.HGP.0.01\/234; date: 10 July 2025). Written informed consent was obtained from all participants prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":3,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}